Ignite Creation Date:
2025-12-24 @ 6:28 PM
Ignite Modification Date:
2026-01-01 @ 10:42 PM
Study NCT ID:
NCT04927468
Status:
UNKNOWN
Last Update Posted:
2021-06-16
First Post:
2021-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy
Sponsor:
Sun Yat-sen University
Organization:
Study Overview
Official Title:
The Management of Large-angle Strabismus in Grave's Ophthalmopathy With Supramaximal Rectus Recession
Status:
UNKNOWN
Status Verified Date:
2021-06
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate supramaximal rectus recession for strabismus in Grave's Ophthalmopathy
Detailed Description:
To evaluate the effectiveness and complications of supramaximal rectus recession for large-angle strabismus in Grave's Ophthalmopathy
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: